UPS Expedites Global Deliveries Of QIAGEN Coronavirus Testing Kits
14 Avril 2020 - 9:00AM
- QIAGEN dramatically ramping up production capacity to get
testing solutions to labs and hospitals across the world via UPS’s
smart global logistics network
- UPS helping QIAGEN deploy products worldwide, including the
first syndromic testing solution that can differentiate novel
Coronavirus from 20 other serious respiratory infections in
approximately one hour
UPS (NYSE:UPS), a global leader in logistics, today announced
that it is working with QIAGEN, a leading global provider of
molecular diagnostics and sample preparation technologies, to
deliver nucleic acid extraction kits critical to COVID-19 testing,
as well as its novel QIAstat-Dx Coronavirus testing cartridges to
destinations around the world. With governments and public
authorities classifying UPS as an essential service provider, the
company is combining the flexibility of its global network with
QIAGEN’s increased production capacity for COVID-19 testing kits
produced at their facility in Hilden, Germany to help healthcare
workers curb the spread of the disease.
“Customers and governments around the world are turning to the
reliability of UPS’s smart global logistics network to help fight
this pandemic,” said Lou Rivieccio, president, UPS Europe.
“Business continuity has never been more important for our
customers and that is what we continue to deliver whether it be for
delivery or storage of medicines, testing kits or medical supplies.
And when it comes to ensuring that increased production volumes of
testing kits reach vital destinations around the world such as
hospitals and labs, our teams are here to help customers navigate
complexity and focus on fighting this pandemic. Agility,
flexibility and fast response in the supply chain arena are helping
to combat this outbreak as it shifts from Asia to Europe and North
America.”
In Europe, UPS has recently invested $2 billion in its network
and services. This investment has allowed the company to implement
dynamic contingency plans that can adapt to the rapidly changing
business environment. Despite recent border closures, UPS is
continuing to serve the needs of its customers. Through its
European air hub at Cologne-Bonn Airport, the company is able to
ensure swift and efficient transportation of essential shipments in
Europe and to destinations around the world.
“We have and continue to increase our production of reagents and
COVID-19 testing kits to meet the current extraordinary demand for
our products worldwide. Our supply chains, both to our production
facilities as well as to our customers in laboratories and
hospitals are crucial at this time,” said Barthold Piening, Senior
Vice President, Head of Global Operations at QIAGEN. “Just as our
teams at QIAGEN are working 24/7 to ensure production we know we
can rely upon UPS as our logistics partner to make sure these kits
and components arrive on time and in the right condition to where
they’re needed most. We share our ambition with UPS, with its
flexible global network, to make our solutions as widely available
as possible.”
These efforts to support QIAGEN’s global needs to respond to a
global challenge with sophisticated supply chain management are in
line with UPS’s support of governments and other private sector
customers working to curb the Coronavirus pandemic. UPS is a
significant part of the world economy, transporting three percent
of global GDP every day, and its employees are proud of the
critical role the company plays for its customers, communities and
the economies in countries where it operates. The company is
supporting public health bodies around the world with the shipment
of crucial healthcare equipment, including the recent shipment of
ventilators to the UK’s National Health Service. To support the
global relief effort in response to the novel Coronavirus, the UPS
Foundation announced new grant allocations to United Nations
agencies, humanitarian relief partners and international
non-government organizations. In the United States, UPS is
supporting Federal Emergency Management Agency (FEMA) with “Project
Airbridge”, a coordinated effort to expedite the arrival of
critical supplies needed in US hospitals.
UPS Healthcare provides extensive services ranging from
healthcare-licensed distribution space, supply chain management, to
temperature-control packaging and shipping, storage and fulfillment
of medical devices, labs and clinical trial specimens. With
capabilities for GDP- and GMP-compliant warehousing and transport
of critical shipments, UPS Healthcare’s global infrastructure,
monitoring and tracking capabilities, and private data protection
are well-suited to help those on the front lines to flatten the
curve of this virus’s impact.
About UPS
UPS (NYSE: UPS) is a global leader in logistics, offering a
broad range of solutions including transporting packages and
freight; facilitating international trade, and deploying advanced
technology to more efficiently manage the world of business.
Headquartered in Atlanta, UPS serves more than 220 countries and
territories worldwide. UPS was awarded America’s Best Customer
Service company for Shipping and Delivery services by Newsweek
magazine; Forbes Most Valuable Brand in Transportation; and top
rankings on the JUST 100 list for social responsibility, the Dow
Jones Sustainability World Index, and the Harris Poll Reputation
Quotient, among other prestigious rankings and awards. The company
can be found on the web at ups.com or pressroom.ups.com and its
corporate blog can be found at ups.com/longitudes The company’s
sustainability eNewsletter, UPS Horizons, can be found
at ups.com/sustainabilitynewsletter. To get UPS news direct,
follow @UPS_News on Twitter. To ship with UPS, visit
ups.com/ship.
Giovanni Mastrobuono
+32 2 776 95 39
gmastrobuono@ups.com
United Parcel Service (NYSE:UPS)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
United Parcel Service (NYSE:UPS)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024